Nebivolol Hcl
Brand names: Bystolic, Nebivolol Hcl
At a glance
- Medicare prescriptions, 2024
- 1,005,365
- Medicare drug cost
- $58.5M
- Average cost per prescription
- $58.17
- Clinicians who prescribed it
- 34,282
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
1. INDICATIONS AND USAGE BYSTOLIC is a beta-adrenergic blocking agent indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
From the FDA-approved prescribing information (label dated July 2024). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Internal Medicine 26.7%
- Family Medicine 23.4%
- Cardiology 22.7%
- Nurse Practitioners 10.3%
- Interventional Cardiology 7.2%
- Physician Assistants 3.6%
- Nephrology (Kidney) 1.6%
- Cardiac Electrophysiology 1.0%
- Geriatric Medicine 0.8%
- General Practice 0.7%
- Endocrinology & Diabetes 0.3%
- Pulmonology 0.2%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions fell 16% from 2019 to 2024.
Biggest change by state since 2019
- Alabama +3%
- Utah +3%
- Maryland +1%
- Florida −5%
- Virginia −6%
- Iowa (smallest change) −43%
- Rhode Island (smallest change) −32%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 1 maker on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Allergan, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 2.5 mg | blue triangle tablet, 8 mm | 2 1 2 FL |
| 5 mg | brown triangle tablet, 10 mm | 5 FL |
| 10 mg | purple triangle tablet, 10 mm | 10 FL |
| 20 mg | blue triangle tablet, 10 mm | 20 FL |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
2 recalls since 2020
- Nov 2025 · Glenmark Pharmaceuticals Inc., USA · Class III
Cross Contamination with Other Products - Dec 2024 · Aurobindo Pharma USA Inc · Class II
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit.
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.